UnitedHealth’s i3 Unit Tapped By FDA To Provide Postmarketing Surveillance
This article was originally published in The Pink Sheet Daily
Executive Summary
The company is close to reaching additional deals with manufacturers for use of its i3 Aperio postmarketing surveillance drug registry.